based on 29 analysts
79.31%
Buy
10.34%
Hold
10.34%
Sell
Based on 29 analysts offering long term price targets for Apollo Hospitals Enterprise Ltd. An average target of ₹7899.69
Source: S&P Global Market Intelligence
Apollo Hospitals Enterprise Ltd price forecast by 29 analysts
Upside of9.21%
High
₹8702
Target
₹7899.69
Low
₹5700
Apollo Hospitals Enterprise Ltd target price ₹7899.69, a slight upside of 9.21% compared to current price of ₹7233.3. According to 29 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Apollo Hospitals Enterprise Ltd revenue growth forecast
Expected growth rate Q1, FY2026:38.45%
Forecast
Actual
Including amortisation and stock based compensations
Apollo Hospitals Enterprise Ltd EPS growth forecast
EPS estimate Q1, FY2026:120.18%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -2.58 % |
3 Month Return | + 5.43 % |
1 Year Return | + 32.44 % |
Market Stats | |
Previous Close | ₹7,274.75 |
Open | ₹7,263.00 |
Volume | 1.89L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹1,04,599.74Cr |
P/E Ratio | 87.91 |
PEG Ratio | 2.6 |
Market Cap | ₹1,04,599.74 Cr |
P/B Ratio | 11.85 |
EPS | 63.77 |
Dividend Yield | 0 |
Sector | Healthcare |
ROE | 13.81 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹1,04,599.74 Cr | 82.47% | 0.65 | ₹917 Cr | ₹19,059 Cr | |
BUY | ₹1,06,633.16 Cr | 176.18% | 0.53 | ₹1,057 Cr | ₹5,704 Cr | |
BUY | ₹52,390.32 Cr | 84.04% | 0.54 | ₹645 Cr | ₹7,175 Cr | |
BUY | ₹26,783.53 Cr | 69.2% | 0.69 | ₹789 Cr | ₹5,018 Cr | |
BUY | ₹24,634.55 Cr | 41.33% | 0.58 | ₹336 Cr | ₹2,498 Cr |
Organisation | Apollo Hospitals Enterprise Ltd |
Headquarters | Chennai |
Industry | Healthcare |
E-voting on shares | Click here to vote |
Key events for Apollo Hospitals Enterprise Ltd
Apollo Hospitals Performs India's First DRG Stimulation Surgery - 28 Nov, 2024
Motilal Oswal Recommends Buy on Apollo Hospitals - 26 Nov, 2024
Apollo Hospitals Receives Positive Buy Rating - 22 Nov, 2024
Apollo Hospitals Reports Strong Q2 Growth - 18 Nov, 2024
Apollo Hospitals Faces Revenue Challenges, Yet Maintains Growth Outlook - 11 Nov, 2024
Apollo Hospitals Reports Strong Q2 Performance - 08 Nov, 2024
Apollo Hospitals Reports Strong Q2 Earnings and Expansion Plans - 07 Nov, 2024
Apollo Hospitals Q2 Profit Surges Exceeding Estimates - 06 Nov, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 11 quarters, 3.58K Cr → 5.63K Cr (in ₹), with an average increase of 4.4% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 43.92% to 45.37% in Sep 2024 quarter
Profit Spike
Netprofit is up for the last 7 quarters, 144.5 Cr → 378.8 Cr (in ₹), with an average increase of 14.4% per quarter
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 85.3% return, outperforming this stock by 52.8%
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 202.5% return, outperforming this stock by 166.4%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 29.33% of holdings in Sep 2024 quarter
Price Dip
In the last 1 month, APOLLOHOSP stock has moved down by -2.6%
Retail Holding Down
Retail Investor have decreased holdings from 5.38% to 5.12% in Sep 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 14.71% to 12.80% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 29.33% | 0.00 | |
Foreign Institutions | 45.37% | 3.30 | |
Mutual Funds | 12.8% | ||
Retail Investors | 5.12% | ||
Others | 7.38% | 10.84 |
Apollo Hospitals Enterprise Ltd in the last 5 years
Lowest (33.30x)
April 1, 2020
Today (87.91x)
December 6, 2024
Industry (103.33x)
December 6, 2024
Highest (341.36x)
June 29, 2021
Apollo Hospitals Enterprise Ltd’s net profit jumped 62.64% since last year same period to ₹378.80Cr in the Q2 2024-2025. On a quarterly growth basis, Apollo Hospitals Enterprise Ltd has generated 24.12% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Apollo Hospitals Enterprise Ltd has declared dividend of ₹10 - translating a dividend yield of 0.35%.
Read More about DividendsBearish
Neutral
Bullish
Apollo Hospitals Enterprise Ltd is currently in a Bullish trading position according to technical analysis indicators.
Apollo Hospitals Enterprise Ltd (APOLLOHOSP) share price today is ₹7233.3
Apollo Hospitals Enterprise Ltd is listed on NSE
Apollo Hospitals Enterprise Ltd is listed on BSE
PE Ratio of Apollo Hospitals Enterprise Ltd is 87.91
PE ratio = Apollo Hospitals Enterprise Ltd Market price per share / Apollo Hospitals Enterprise Ltd Earnings per share
Today’s traded volume of Apollo Hospitals Enterprise Ltd(APOLLOHOSP) is 1.89L.
Today’s market capitalisation of Apollo Hospitals Enterprise Ltd(APOLLOHOSP) is ₹104599.74Cr.
Apollo Hospitals Enterprise Ltd(APOLLOHOSP | Price |
---|---|
52 Week High | ₹7545 |
52 Week Low | ₹5284.85 |
Apollo Hospitals Enterprise Ltd(APOLLOHOSP) share price is ₹7233.3. It is down -4.13% from its 52 Week High price of ₹7545
Apollo Hospitals Enterprise Ltd(APOLLOHOSP) share price is ₹7233.3. It is up 36.87% from its 52 Week Low price of ₹5284.85
Apollo Hospitals Enterprise Ltd(APOLLOHOSP | Returns |
---|---|
1 Day Returns | -41.45% |
1 Month Returns | -2.58% |
3 Month Returns | 5.43% |
1 Year Returns | 32.44% |